Logistics: Customer & Regulatory Expectations versus Daily Reality Marian Desmet Benoît Cloquet.

Slides:



Advertisements
Similar presentations
Endothelial Progenitor Cell (EPC) Core Laboratory Instructions Version 5.0 March 29, 2008 For questions regarding collection, processing, storage, or shipping.
Advertisements

CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
HIV Drug Resistance Training
Regulatory Auditing. Audit Areas Management Responsibility Auditing (internal and external) Design Control Document Control Purchasing Control Identification.
HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
1 1 Chapter 1 Specimen Management Professor A. S. Alhomida Disclaimer The texts, tables and images contained in this course presentation (BCH 376) are.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
ISO 9001 : 2000.
Good Clinical Practices Regulatory Guidelines for the Conduct of Clinical research Introduction to Research Pharmacy Services Javier Palacios, R.Ph. Sponsored.
Prerequisite Programme Training Guide
Learning from GMP Inspections. Richard Bateman QA Specialist Pharmacist East and South East England Specialist Pharmacy Services.
Microbiology and Serology
Electronic Business (MGT-485)
Good Manufacturing Practices for Blood Establishments
Clinical Trials Logistics. "BioLogistic" company is represented at the Russian Clinical Trials Logistics market since As a 3PL-provider "BioLogistic"
Investigational Pharmacy Issues Debbie Mundie, RPH Aka: The Drug “Nazi” “She should be in Law Enforcement” “She’s nice, but PICKY” McGuire VAMC Richmond.
QUALITY ASSURANCE Shree Baboolal 12 th February, 2005.
How the ISO/TS Additions have moved from 1st to 2nd edition
World Health Organization
Federal Institute for Drugs and Medical Devices The BfArM is a Federal Institute within the portfolio of the Federal Ministry of Health 1 Quality of Bioequivalence.
Regulatory Overview.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
The Role of the Internal Auditor for Maintaining System Compliance and Promoting Continuous Improvement Wayne M. Uttke
Centralized Sterile Product Preparation Workflow for Anywhere Health System (AHS)
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Synta Pharmaceuticals
« A Driver becomes Monitor » Philippe Van der Hofstadt B & C International, Belgium Conférence CEMO 14 Mars 2001.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Presented by Steven P. Feltman Food Safety and Quality Specialist.
OH 3-1 Receiving and Storing to Maintain Quality Food Production 3 OH 3-1.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
FREEZING POINT OF WATER Freezing is the process in which matter changes from liquid to solid Execution Take a beaker and fill it with ice cubes, cold.
Important informations
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
By: Caleb Harris.  The main purpose of QA is to monitor programs to determine their effectiveness, and if they are ineffective, to implement appropriate.
Step What happens?. Who is responsible? Procedures needed?
Molecule-to-Market-Place Quality
1 1 Poultry Slaughter Exemptions Under the Federal Poultry Products Inspection Act and the SC Poultry Products Inspection Law SC Poultry Products Inspection.
V Overview of PBMC, Serum, Plasma and CSF Samples Holly Lash, Research Biochemist Jennifer Talaty, Medical Program Coordinator.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
Doane Pet Care Company Pet Food Safety System (PFSS) M.W. Merkel September 23, 2003 Animal Feed Safety System Public Meeting.
Good Manufacturing Practices – A Regulatory Perspective Presented By: Ashok Kumar Dua Plant Head – Unichem Laboratories (Sikkim )
Content 1.About us 2.Mission & Vision 3.Values 4.Facility 5.Quality Management System 6.Services 7.Why PCS.
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
Visit us at E mail: Tele:
Regulatory Labeling and Marketing. Which ones are involved in label design and control? Manufacturing Manufacturing Quality Assurance Quality Assurance.
COBIT. The Control Objectives for Information and related Technology (COBIT) A set of best practices (framework) for information technology (IT) management.
Storage of Health Commodities Supply Chain Management.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
External Provider Control
Responsibilities of Sponsor, Investigator and Monitor
INTRO TO SAP EWM.
Quality Control and Assurance
ISO/IEC
QUALITY ASSURANCE AND QUALITY CONTROL IN GENERICS
Quality Assurance and Quality Control in Generics
Good Clinical Practice
Lesson 7: BRITE Seminar: GMP II
Lesson 5: BRITE Seminar: GMP II
Quality Control SOP 3.12 Release Date: 08/10/2015.
MANUFACTURER SURVEY GIRP-IPF STUDY 2016.
Good Laboratory Practices
Good Laboratory Practice CFR 21 Part 58
TRANSFUSIONS IN THE COMMUNITY
Good clinical practice
Presentation transcript:

Logistics: Customer & Regulatory Expectations versus Daily Reality Marian Desmet Benoît Cloquet

B&Cemo Conf/MD/26-Jan-2006/Slide 2 1.Logistics: What is it? Total process of moving goods from a Manufacturer to a Customer in the most timely and cost-efficient manner possible Handling and movement of inbound raw materials and other supplies as well as outbound physical distribution Organisation of any project or operation, including transportation and housing

B&Cemo Conf/MD/26-Jan-2006/Slide 3 2. Clinical Research Regulatory Compliance YES! Safe & Effective

B&Cemo Conf/MD/26-Jan-2006/Slide 4 Patients CT Subjects Declaration of Helsinki/ Hippocratic Oath Good Medical Practice GCP … Contract CT Protocol Good Lab Technical Working Principles National Regulations (e.g. GBEA) Norms (CAP, ISO) 2. Clinical Research Regulatory Compliance

B&Cemo Conf/MD/26-Jan-2006/Slide 5 3.Regulatory & Customer Expectations What do they expect? Compliance? With what? Really mandatory for a company as B & C International? Differences between Customers Different viewpoints & auditing focus between Auditors

B&Cemo Conf/MD/26-Jan-2006/Slide 6 4.Compliance Approach Risk Management Approach? Risk for Regulatory Authority Inspections? Yes Are the data & systems in support of regulatory submissions? Integrate principles of GCP and related applicable regulations, incl. validation

B&Cemo Conf/MD/26-Jan-2006/Slide 7 5. Compliance Examples Laboratory Kit - Tube missing - Expired product in tube - Not delivered at right time QC Error Delay Customs Impact on Result &/or Clinical Trial? -Some tests not performed -Reliable result? - Test out-of Protocol required time-window

B&Cemo Conf/MD/26-Jan-2006/Slide 8 5. Compliance Examples Specimen Storage - 1X/day temperature monitoring - No traceability of removal in- & out in case of specimen transfer (defrosting, cleaning) Impact on Result &/or Clinical Trial? -Evidence of specimen storage at appropriate conditions at all times (incl. Transfer)?

B&Cemo Conf/MD/26-Jan-2006/Slide 9 6. Transport Validation Approach at B & C Pre-testing - Time of ambient specimen to become - refrigerated - frozen at -20°C - frozen at -80°C - In-house TempTale Validation - IQ/OQ/PQ: 1 hour temp. recording - Inter-TempTale Variability: Accuracy Static Testing: Controlled Conditions Dynamic Testing: Life Transport Test

B&Cemo Conf/MD/26-Jan-2006/Slide Transport Validation Approach at B & C: Inter-TempTale Variability N = 18 Temptales Consecutive conditions Test: 4 1/2 h 1 H 30’1 H Room T°2 – 8°C-20°C-80°CRoom T°

B&Cemo Conf/MD/26-Jan-2006/Slide Transport Validation Approach at B & C: Inter-TempTale Variability

B&Cemo Conf/MD/26-Jan-2006/Slide Transport Validation Approach at B & C: Static Test Specimens: 9 (3 X 3) Tubes filled with water Additive for “Position” in shipment container Labelling for original condition - Refrigerated - -20°C - -80°C Probe from TempTale inside tube Shipment container: TempTale sensor on Top / Middle / Bottom

B&Cemo Conf/MD/26-Jan-2006/Slide 13

B&Cemo Conf/MD/26-Jan-2006/Slide 14

B&Cemo Conf/MD/26-Jan-2006/Slide 15 Results: Specimen T° at bottom: Stable The less dry ice surrounding the specimen, specimen T° Effect of opening/closing box on specimen T°: Almost nihil Box T° “Top”: - 45°C to - 20°C (evaporation dry ice) 6. Transport Validation Approach at B & C: Static Test 0’ 5 ½ D 0’ 5 ½ D

B&Cemo Conf/MD/26-Jan-2006/Slide Transport Validation Approach at B & C: Dynamic Test Main Objective: Verification of Life Transport Conditions - 2 specimens (tube with water) - TempTale inside tube - Shipment container: TempTale on Top / at Bottom

B&Cemo Conf/MD/26-Jan-2006/Slide Lessons Learned - Conclusions Added value of Transport Validation -Not the opening of transport boxes important, but the level of dry ice -If specimens need to remain at -80°C, they should be permanently surrounded by dry ice -Specimens half in/half out dry ice: T° variation between -80°C to -45°C